Ranbaxy Laboratories Reports Loss

Ranbaxy Laboratories RBXZF reported a loss in the quarter ended March 31. Ranbaxy posted a quarterly after-tax loss of 736.5 million rupees ($12.26 million). Its drug sales climbed to 24.4 billion rupees, versus 24.1 billion rupees, in the year-earlier period. Its US sales jumped to 7.7 billion rupees versus 5.9 billion rupees.